EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Mesoporous polydopamine delivery system for intelligent drug release and photothermal-enhanced chemodynamic therapy using MnO2 as gatekeeper

Zhaoyang Wang, Zekai Li, Yuehua Shi, Leyong Zeng iD

Regenerative Biomaterials · 17.01.2023 · 10

DOI: 10.1093/rb/rbad087 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Regenerative Biomaterials, online erschienen am 22.09.2023. Verfasst von Zhaoyang Wang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Medicinal Chemistry and Molecular Diagnosis of the Ministry of Education, Chemical Biology Key Laboratory of Hebei Province, State …. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The non-specific leakage of drugs from nanocarriers seriously weakened the safety and efficacy of chemotherapy, and it was very critical of constructing tumor microenvironment (TME)-responsive delivery nanocarriers, achieving the modulation release of drugs. Herein, using manganese dioxide (MnO2) as gatekeeper, an intelligent nanoplatform based on mesoporous polydopamine (MPDA) was developed to deliver doxorubicin (DOX), by which the DOX release was precisely controlled, and simultaneously the photothermal therapy (PTT) and chemodynamic therapy (CDT) were realized. In normal physiological environment, the stable MnO2 shell effectively avoided the leakage of DOX. However, in TME, the overexpressed glutathione (GSH) degraded MnO2 shell, which caused the DOX release. Moreover, the photothermal effect of MPDA and the Fenton-like reaction of the generated Mn2+ further accelerated the cell death. Thus, the developed MPDA-DOX@MnO2 nanoplatform can intelligently modulate the release of DOX, and the combined CDT/PTT/chemotherapy possessed high-safety and high-efficacy against tumors.

Schlagwörter

Stichwörter der Autor:innen

MnO2 gatekeeperchemodynamic therapychemotherapymesoporous polydopaminephotothermal therapy

Autor:innen und Institutionen

  • Key Laboratory of Medicinal Chemistry and Molecular Diagnosis of the Ministry of Education, Chemical Biology Key Laboratory of Hebei Province, State Key Laboratory of New Pharmaceutical Preparations and Excipients, Coll…

ORCID-Profile: Leyong Zeng

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Wang, Z., Li, Z., Shi, Y., & Zeng, L. (2023). Mesoporous polydopamine delivery system for intelligent drug release and photothermal-enhanced chemodynamic therapy using MnO2 as gatekeeper. Regenerative Biomaterials, 10. https://doi.org/10.1093/rb/rbad087

Vancouver

Wang Z, Li Z, Shi Y, Zeng L. Mesoporous polydopamine delivery system for intelligent drug release and photothermal-enhanced chemodynamic therapy using MnO2 as gatekeeper. Regenerative Biomaterials. 2023;10. doi:10.1093/rb/rbad087

BibTeX
@article{Wang2023,
  author = {Wang, Zhaoyang and Li, Zekai and Shi, Yuehua and Zeng, Leyong},
  title = {Mesoporous polydopamine delivery system for intelligent drug release and photothermal-enhanced chemodynamic therapy using MnO2 as gatekeeper},
  journal = {Regenerative Biomaterials},
  year = {2023},
  volume = {10},
  doi = {10.1093/rb/rbad087}
}
Kostenlos starten →